4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-005263
Options or other derivatives
- Chief Medical Officer acquired 337,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Norry Elliot Chief Medical Officer | 2020-01-16 | Grant or award · Option to purchase Ordinary Shares | +201,600 | 201,600 | D | ||
| Norry Elliot Chief Medical Officer | 2020-01-16 | Grant or award · Option to purchase Ordinary Shares | +135,600 | 135,600 | D | ||
Loading xslF345X03/a4.xml…